Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer
Authors
Hoyle, Alex PAli, S
James, N
Parker, C
Cook, A
Attard, G
Chowdhury, S
Cross, W
Dearnaley, D
de Bono, J
Gilson, C
Gillessen, Silke
Jones, R
Matheson, D
Mason, M
Ritchie, A
Russell, M
Parmar, M
Sydes, M
Clarke, Noel W
Affiliation
Uro-Oncology, The Christie NHS Foundation Trust, Manchester, UKIssue Date
2018
Metadata
Show full item recordCitation
Hoyle AP, Ali SA, James ND, Parker CC, Cook AD, Attard G, et al. Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer. Ann Oncol. 2018;29(suppl_8):722.Journal
Annals of OncologyDOI
10.1093/annonc/mdy424.033Additional Links
https://dx.doi.org/10.1093/annonc/mdy424.033Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy424.033